Vitamin D3 + K2: Dosing, Targets, and Why You're Still Low

Roughly 40% of U.S. adults are vitamin D deficient by the conservative 20 ng/mL cutoff, and closer to 70% fall below the functional 40 ng/mL target many clinicians use (Forrest & Stuhldreher, 2011). What surprises patients is how many of them are already taking vitamin D and still show up low on labs. The reason is almost always some combination of underdosing, poor absorption, and skipping the cofactor — vitamin K2 — that tells calcium where to go once D3 has pulled it into the bloodstream.

This is the plain-English version of how to dose D3, why K2 belongs in the same capsule, and what number you should actually be chasing on your next 25-hydroxy vitamin D panel.

Why vitamin D deficiency is still this common

Vitamin D is technically a hormone, not a vitamin. Your skin makes it from UVB exposure, your liver converts it to 25-hydroxyvitamin D (the storage form we measure), and your kidneys convert that to the active 1,25-dihydroxy form. Every step is fragile.

The common reasons patients stay deficient despite supplementing:

• Dose too low. A 1,000 IU daily dose — the standard drugstore softgel — raises serum 25(OH)D by only about 10 ng/mL in most adults (Heaney et al., 2003). If you started at 22 ng/mL, you're now at 32. Still under target.
• Taken without fat. D3 is fat-soluble. Taken on an empty stomach or with a low-fat breakfast, absorption can drop 30–50%.
• Higher body fat. Adipose tissue sequesters vitamin D, meaning patients with a higher BMI need meaningfully more to hit the same serum level.
• Darker skin, northern latitude, or indoor work. All three cut endogenous production.
• Gut issues. Celiac, IBD, gastric bypass, and chronic bile-acid issues all impair fat-soluble vitamin absorption.

Supplementing 1,000 IU and hoping is the most common mistake. Testing is the only way to know.

What blood level are we actually aiming for?

The lab reference range on most panels reads something like "30–100 ng/mL," but that bottom number reflects the threshold below which frank deficiency disease (rickets, osteomalacia) becomes likely. It is not an optimum.

Most integrative and preventive clinicians target 40–60 ng/mL on serum 25-hydroxyvitamin D. That range is associated with:

• Maximal suppression of parathyroid hormone (a good proxy for "the body has enough D")
• Better bone density outcomes
• Fewer respiratory infections in trial data (Martineau et al., 2017)

Above 100 ng/mL you're in territory where the risk-benefit inverts, and above 150 ng/mL you can see hypercalcemia. The goal is a wide, boring middle: 40–60, retested annually.

If your 25(OH)D is 32 ng/mL and your lab report says "normal," your lab is using the disease-prevention floor, not a performance target.

D3 dosing that actually moves the number

Rather than a fixed prescription, think in terms of the rough conversion: every 1,000 IU of daily D3 raises serum 25(OH)D by ~10 ng/mL over 8–12 weeks, with wide individual variation.

Published maintenance dosing for adults generally sits in the 1,000–4,000 IU per day range, with the Endocrine Society noting that up to 10,000 IU/day is unlikely to cause toxicity in adults (Holick et al., 2011). Practical framing:

• Starting at 20–30 ng/mL, most adults need 2,000–4,000 IU daily to reach the 40–60 range.
• Higher body weight typically needs the upper end of that range.
• Take it with your largest fat-containing meal. This is not optional; it changes absorption significantly.
• Daily dosing outperforms weekly mega-doses for stable serum levels.

Retest at 10–12 weeks. Adjust. Retest again in a year. This is the whole protocol.

{callout: The single most important line} Take D3 with fat, pair it with K2, and retest at 10–12 weeks — a bottle of D3 without a follow-up lab is a guess.

Why K2 belongs in the same capsule

Vitamin D3 increases calcium absorption from the gut. That's the point. But what happens to that calcium depends on vitamin K2, which activates two proteins:

• Osteocalcin, which pulls calcium into bone.
• Matrix Gla protein (MGP), which keeps calcium out of arteries and soft tissue.

Without adequate K2, higher D3 dosing can theoretically shift calcium in the wrong direction — into vascular tissue rather than bone. The clinical data on hard cardiovascular endpoints is still maturing, but observational work like the Rotterdam Study linked higher K2 (menaquinone) intake to lower coronary calcification and cardiovascular mortality (Geleijnse et al., 2004).

The mechanistic logic is clean enough that most clinicians pairing D3 above 2,000 IU/day will pair it with K2.

MK-4 vs MK-7 — the K2 form question

K2 comes in two supplemental forms:

• MK-4: shorter half-life (~1 hour), typically dosed 2–3x daily at higher amounts.
• MK-7: half-life of ~72 hours, dosed once daily. Most stacks use this.

Typical MK-7 dosing in the literature runs 90–180 mcg per day, taken with the D3 dose. It's fat-soluble, so same rule: take it with a meal that contains fat.

Who should be more careful with K2

K2 is generally well tolerated, but there is one meaningful interaction: warfarin. Warfarin works by antagonizing vitamin K, so adding K2 can blunt its effect. Patients on warfarin should not add K2 without their prescribing clinician adjusting INR monitoring.

Direct oral anticoagulants (apixaban, rivaroxaban) do not have this interaction.

The labs worth having before starting

If you're building a serious supplement stack, the markers worth having on file are:

• 25-hydroxy vitamin D — the baseline and follow-up number
• Calcium (serum) — to make sure you're not already high
• PTH — elevated PTH with low-normal D suggests functional deficiency even if D looks okay
• Magnesium — magnesium is a required cofactor for converting D to its active form; low magnesium blunts your D response

A thorough workup would typically include those four, plus a basic metabolic panel to check kidney function. If you choose to do bloodwork through us, this is the cluster we'd look at first for anyone chasing a D target.

Common mistakes we see on follow-up labs

After 90 days on a D3 + K2 protocol, the patients who didn't move their number usually did one of these:

1. Took it on an empty stomach. Absorption tanks. Move it to dinner. 2. Stopped and started. D3 needs consistency; you're refilling a body pool, not spiking a hormone. 3. Underdosed for their body weight. 2,000 IU is a starting dose, not a ceiling. 4. Ignored magnesium. Low RBC magnesium keeps D from converting efficiently. 5. Bought a low-quality softgel. Look for third-party tested products with the actual IU on the certificate of analysis.

The plain-English plan

• Test 25(OH)D. If you're below 40 ng/mL, you have room to move.
• Start D3 at 2,000–4,000 IU daily, with your largest fat-containing meal.
• Pair it with K2 (MK-7) at 90–180 mcg daily.
• Check magnesium status; supplement if low.
• Retest at 10–12 weeks. Adjust dose based on where you landed.
• Once you're in the 40–60 ng/mL range, an annual retest is usually enough.

That's it. No mystery, no megadose heroics — just a fat-soluble vitamin, its cofactor, and a follow-up lab that tells you whether the plan is working.

Editorial disclosure: This article is for informational purposes only and does not constitute medical advice. All treatments at DirectCare AI are prescribed by US-licensed clinicians based on individual medical evaluation. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a US-licensed clinician before starting or changing any therapy.